Prediagnostic body mass index and pancreatic cancer survival

Journal of Clinical Oncology

Volumn 31, Issue 33, 2013, Pages 4229-4234

  Yuan, Chen ^a   Bao, Ying ^b   Wu, Chen ^c   Kraft, Peter ^c   Ogino, Shuji ^a,b,c   Ng, Kimmie ^a,b   Qian, Zhi Rong ^a   Rubinson, Douglas A ^a   Stampfer, Meir J ^b,c   Giovannucci, Edward L ^b,c   Wolpin, Brian M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; ETHNICITY; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PANCREAS CANCER; PREDICTIVE VALUE; PRIORITY JOURNAL; RACE; SELF REPORT; SEX; SMOKING; SURVIVAL TIME; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS TUMOR; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL RATE; VERY ELDERLY; COMPLICATION; PANCREATIC NEOPLASMS; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84892896996     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.7532     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63:11-30, 2013
2. Hidalgo M: Pancreatic cancer. N Engl J Med 362:1605-1617, 2010
3. Michaud DS, Giovannucci E, Willett WC, et al: Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286:921-929, 2001 (Pubitemid 33010338)
4. Arslan AA, Helzlsouer KJ, Kooperberg C, et al: Anthropometric measures, body mass index, and pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med 170:791-802, 2010
5. Larsson SC, Orsini N, Wolk A: Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies. Int J Cancer 120:1993-1998, 2007 (Pubitemid 46418379)
6. Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al: Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294: 2872-2878, 2005 (Pubitemid 41785868)
7. Bao Y, Giovannucci EL, Kraft P, et al: A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst 105:95-103, 2013
8. Wolpin BM, Bao Y, Qian ZR, et al: Hyperglycemia, insulin resistance, impaired pancreatic betacell function and risk of pancreatic cancer. J Natl Cancer Inst 105:1027-1035, 2013
9. Grote VA, Rohrmann S, Nieters A, et al: Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: A study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia 54:3037-3046, 2011
10. Li N, Grivennikov SI, Karin M: The unholy trinity: Inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19:429- 431, 2011
11. Gukovsky I, Li N, Todoric J, et al: Inflammation, autophagy, and obesity: Common features in the pathogenesis of pancreatitis and pancreatic cancer. Gastroenterology 144:1199.e4-1209.e4, 2013
12. Pannala R, Leibson CL, Rabe KG, et al: Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 104:2318-2325, 2009
13. Pannala R, Basu A, Petersen GM, et al: Newonset diabetes: A potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88-95, 2009
14. Colditz GA, Hankinson SE: The Nurses' Health Study: Lifestyle and health among women. Nat Rev Cancer 5:388-396, 2005 (Pubitemid 40637830)
15. Giovannucci E, Ascherio A, Rimm EB, et al: Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann Intern Med 122:327-334, 1995
16. Mozaffarian D, Hao T, Rimm EB, et al: Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364:2392- 2404, 2011
17. Rich-Edwards JW, Corsano KA, Stampfer MJ: Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 140:1016-1019, 1994 (Pubitemid 24373006)
18. Wang DS, Wang ZQ, Zhang L, et al: Are risk factors associated with outcomes in pancreatic cancer? PLoS ONE 7:e41984, 2012
19. Cochran WG: The combination of estimates from different experiments. Biometrics 10:101-129, 1954
20. Li D, Morris JS, Liu J, et al: Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 301:2553-2562, 2009
21. Olson SH, Chou JF, Ludwig E, et al: Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 127:2412-2419, 2010
22. McWilliams RR, Matsumoto ME, Burch PA, et al: Obesity adversely affects survival in pancreatic cancer patients. Cancer 116:5054-5062, 2010
23. Bilimoria KY, Bentrem DJ, Ko CY, et al: Validation of the 6th edition AJCC Pancreatic Cancer Staging System: Report from the National Cancer Database. Cancer 110:738-744, 2007 (Pubitemid 47257648)
24. Yachida S, Jones S, Bozic I, et al: Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114-1117, 2010
25. Haeno H, Gonen M, Davis MB, et al: Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148:362-375, 2012
26. Zyromski NJ, Mathur A, Pitt HA, et al: Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery 146:258-263, 2009
27. Vansaun MN: Molecular pathways: Adiponectin and leptin signaling in cancer. Clin Cancer Res 19:1926-1932, 2013
28. Pollak M: The insulin and insulin-like growth factor receptor family in neoplasia: An update. Nat Rev Cancer 12:159-169, 2012
29. White PB, True EM, Ziegler KM, et al: Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg 14:1888- 1893, 2010; discussion 1893-1894
30. Mathur A, Zyromski NJ, Pitt HA, et al: Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg 208:989-994, 2009; discussion 994-996
31. House MG, Fong Y, Arnaoutakis DJ, et al: Preoperative predictors for complications after pancreaticoduodenectomy: Impact of BMI and body fat distribution. J Gastrointest Surg 12:270-278, 2008
32. Khan S, Sclabas G, Reid-Lombardo K, et al: Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg 14:1820-1825, 2010